Drug resistance in Leishmania parasites. Consequences, Molecular Mechanisms, and possible treatments
Forward for “Drug Resistance in Leishmania Parasites” Therapeutic unresponsiveness presents a formidable obstacle to the efficient clinical management of many diseases. This is especially true in the case of greatly neglected diseases, such as leishmaniasis, for which the drugs currently in clinical...
שמור ב:
| יצא לאור: |
2012
|
|---|---|
| נושאים: | |
| גישה מקוונת: | http://hdl.handle.net/10872/2032 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
פריטים דומים: Drug resistance in Leishmania parasites. Consequences, Molecular Mechanisms, and possible treatments
- Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?
- Leishmania spp.: proficiency of drug-resistant parasites
- Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?
- Sensitivity of Leishmania spp. to glibenclamide and 4-aminopyridine: a tool for the study of drug resistance development.
- Substrate preferences and glucose uptake in glibenclamide-resistant Leishmania parasites
- Molecular Pharmacology of Chemo-resistant Leishmania
